Candel Therapeutics, Inc. (CADL) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Candel Therapeutics, Inc. (CADL) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

CADL Cash Flow Statement

Candel Therapeutics, Inc. (CADL) cash flow statement — 7-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-17.18M	-18.04M	-10.57M	-10.24M	-8.89M	-8.62M	-5.81M	-6.57M	-6.2M	-8.44M	-7.42M	-8.81M	-7.2M	-10.82M	-6.88M	-9.38M	-7.1M	-8.05M	-5.24M	-6.89M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-22209.68%	-30270.97%	-22893.55%	-25977.42%	-16896.77%	-22238.71%
Operating CF Growth %	-93.25%	-109.34%	-81.77%	-55.73%	-43.45%	-2.11%	21.67%	25.37%	13.86%	22.01%	-7.8%	6.14%	-1.38%	-34.35%	-31.44%	-36.12%	-59.16%	-43.11%	-53.34%	-
Net Income	-38.91M	-8.86M	-29.5M	-11.27M	-4.8M	7.38M	-14.07M	-10.65M	-22.24M	-8.22M	-11.1M	-8.44M	-9.61M	-8.79M	-5.08M	-8.69M	-4.15M	-874K	1.6M	-16.16M
Depreciation & Amortization	171K	149K	163K	195K	242K	245K	245K	245K	249K	251K	335K	245K	236K	230K	221K	205K	187K	165K	178K	21K
Stock-Based Compensation	2.86M	1.45M	1.29M	1.16M	1.05M	314K	1.24M	1.18M	1.84M	1.04M	939K	686K	733K	733K	634K	743K	438K	492K	-446K	1.91M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-416K	-144K	0	0	0	0	0	0	0
Other Non-Cash Items	11.03M	-7.21M	13.88M	-681K	-5.45M	-14.73M	6.03M	1.8M	13.51M	171K	818K	170K	163K	-492K	-2.59M	-199K	-4.81M	-8.18M	-8.63M	8.27M
Working Capital Changes	7.66M	-3.57M	3.6M	356K	67K	-1.82M	743K	844K	441K	-1.68M	1.58M	-1.06M	1.43M	-2.5M	-71K	-1.45M	1.24M	347K	2.06M	-932K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	2.38M	1.7M	33K	-744K	1.01M	507K	-56K	-140K	-39K	50K	0	-214K	-62K	149K	-544K	-508K	418K	-579K	665K	181K
Cash from Investing	-69K	-675K	-409K	-117K	-31K	-3K	-3K	0	-6K	-7K	-27K	-103K	-169K	19K	-276K	-215K	-635K	-171K	-504K	-392K
Capital Expenditures	-69K	-675K	-409K	-144K	-31K	-3K	-3K	0	-6K	-7K	-47K	-103K	-169K	-138K	-276K	-215K	-635K	-171K	-504K	-392K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	890.32%	693.55%	2048.39%	551.61%	1625.81%	1264.52%
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	27K	0	0	0	0	0	0	20K	0	0	157K	0	0	0	0	0	0
Cash from Financing	23.98M	93.81M	43.9M	-3.37M	17.44M	-1.87M	91.91M	1.68M	1.95M	-1.25M	-121K	0	0	0	36K	0	22K	19.92M	0	71.36M
Debt Issued (Net)	0	0	7.5M	-2.5M	-2.5M	-2.5M	-2.5M	-2.5M	-2.5M	-1.67M	0	0	0	0	0	0	0	19.91M	0	0
Equity Issued (Net)	23.98M	93.81M	4K	-713K	19.7M	384K	94.04M	4.07M	3.46M	186K	-121K	0	0	0	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	-121K	0	0	0	0	0	0	0	0	0
Other Financing	0	0	36.39M	-158K	246K	246K	370K	103K	990K	226K	0	0	0	0	36K	0	22K	6K	0	71.36M
Net Change in Cash	6.73M	75.1M	32.92M	-13.72M	8.52M	-10.49M	86.1M	-4.9M	-4.26M	-9.7M	-7.57M	-8.91M	-7.36M	-10.8M	-7.13M	-9.6M	-7.71M	11.69M	-5.74M	64.07M
Free Cash Flow	-17.25M	-18.71M	-10.98M	-10.38M	-8.92M	-8.62M	-5.82M	-6.57M	-6.2M	-8.45M	-7.47M	-8.91M	-7.36M	-10.96M	-7.16M	-9.6M	-7.73M	-8.22M	-5.74M	-7.29M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-23100%	-30964.52%	-24941.94%	-26529.03%	-18522.58%	-23503.23%
FCF Growth %	-93.35%	-117.1%	-88.71%	-57.92%	-43.81%	-2.06%	22.12%	26.24%	15.75%	22.93%	-4.3%	7.17%	4.76%	-33.23%	-24.71%	-31.75%	-49.58%	-40.44%	-48.41%	-
FCF per Share	-0.23	-0.30	-0.20	-0.19	-0.17	-0.27	-0.16	-0.21	-0.21	-0.29	-0.26	-0.31	-0.25	-0.38	-0.25	-0.33	-0.27	-0.29	-0.25	-0.31
FCF Conversion (FCF/Net Income)	0.44x	2.04x	0.36x	0.91x	1.85x	-1.17x	0.41x	0.62x	0.28x	1.03x	0.67x	1.04x	0.75x	1.23x	1.35x	1.08x	1.71x	9.21x	-3.28x	0.43x
Interest Paid	1.22M	0	-571K	127K	192K	252K	333K	421K	0	549K	556K	555K	537K	500K	309K	515K	211K	117K	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	-168K	168K	0	27K	23K	48K	85K	1K	7K